VICC Annual Scientific Retreat
|
The Vanderbilt-Ingram Cancer Center (VICC) 23rd Annual Scientific Retreat will be held on May 2nd, 2022 in the Student Life Center with national and international experts presenting on the Advances in Lung Cancer Research. The VICC retreat has a long tradition of providing opportunities for collaborative interactions and discussions between investigators, community partners, students and trainees. We look forward to your attendance this year, and ask that you check back to this webpage for more updates soon! |
|
 |
The Vanderbilt-Ingram Cancer Center’s 23rd Annual Scientific Retreat is being held in honor of the life and work of Pierre Massion, MD. Dr. Massion's work embodied the Vanderbilt-Ingram Cancer Center's mission to alleviate cancer death and suffering through pioneering research; patient-centered care; evidence-based prevention, education, and community activities. His innovative research and impassioned patient-centered care led to many groundbreaking discoveries related to the evolution of pulmonary nodules, the development of biomarkers for lung cancer detection, and state-of-the-art screening protocols to improve early detection of lung cancer. In addition to his pioneering work, Dr. Massion was a beloved colleague and friend to clinicians and investigators around the world. He was passionate about education and mentoring as evidenced by the dozens of junior faculty, postdoctoral trainees, graduate students, undergraduates, and summer students he interacted with. At the center of his heart were his wife Tebeb Gebretsadik and his three sons, Samuel, Thomas, and Elias. The picture of the two yellow daffodils was taken by Dr. Massion on March 21, 2021, for his wife, Tebeb Gebretsadik. |
Featured Speakers:
Denise Aberle, MD
(UCLA Jonsson Comprehensive Cancer Center)
is a professor of Radiology in the School of Medicine and professor of Bioengineering in the Henry Samueli School of Engineering and Applied Sciences. She is board-certified in Internal Medicine and Diagnostic Radiology. Dr. Aberle's research centers on lung cancer screening, early diagnosis, prevention, and screening implementation. Other interests include oncologic imaging for response assessment; quantitative image analysis, and oncology informatics.
M. Patricia Rivera, MD, ATSF, FCCP
(URMC Wilmot Cancer Center)
is the C. Jane Davis & C. Robert Davis Distinguished Professor in Pulmonary Medicine, Chief of the Division of Pulmonary Diseases and Critical Care Medicine at the University of Rochester Medical Center (URMC), and Associate Director of Diversity, Equity and Inclusion at the Wilmot Cancer Center. Dr. Rivera specializes in lung cancer screening, diagnosis, staging, and management of treatment complications.
Julien Sage, PhD
(Stanford Cancer Institute)
is the Elaine and John Chambers Professor in Pediatric Cancer and a Professor of Genetics at Stanford University where he serves as the co-Director of the Cancer Biology PhD program. Dr. Sage became initially interested in small cell lung cancer because of the nearly ubiquitous loss of RB in this cancer type and the intriguing relationship in mice and humans between loss of RB and the growth of neuroendocrine lesions. In the past few years, the Sage lab has developed pre-clinical models for small cell lung cancer and has used these models to investigate signaling pathways driving the growth of this cancer type and to identify novel therapeutic targets in this recalcitrant cancer.
Sudhir Srivastava, PhD, MPH
(National Cancer Institute)
is the Chief of the Cancer Biomarkers Research Group at the National Cancer Institute. His efforts focus on molecular biology of malignancies, early malignancies, risk assessment, and informatics, providing leadership in the areas of molecular screening and early detection. He is one of the principal authors of the Bethesda Guidelines for diagnosing Hereditary non-polyposis colorectal cancer.
